Cargando…
Radiation therapy and secondary malignancy in Li‐Fraumeni syndrome: A hereditary cancer registry study
BACKGROUND: Li‐Fraumeni Syndrome (LFS) is a rare cancer‐predisposing condition caused by germline mutations in TP53. Conventional wisdom and prior work has implied an increased risk of secondary malignancy in LFS patients treated with radiation therapy (RT); however, this risk is not well‐characteri...
Autores principales: | Hendrickson, Peter G., Luo, Yukun, Kohlmann, Wendy, Schiffman, Josh, Maese, Luke, Bishop, Andrew J., Lloyd, Shane, Kokeny, Kristine E., Hitchcock, Ying J., Poppe, Matthew M., Gaffney, David K., Tao, Randa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643676/ https://www.ncbi.nlm.nih.gov/pubmed/32931654 http://dx.doi.org/10.1002/cam4.3427 |
Ejemplares similares
-
Li-Fraumeni Syndrome
por: Vogel, Wendy H.
Publicado: (2017) -
A novel TP53 tandem duplication in a child with Li–Fraumeni syndrome
por: Xu, Feng, et al.
Publicado: (2022) -
Breast cancer characteristics and surgery among women with Li‐Fraumeni syndrome in Germany—A retrospective cohort study
por: Rippinger, Nathalie, et al.
Publicado: (2021) -
Multiple Germline Events Contribute to Cancer Development in Patients with Li-Fraumeni Syndrome
por: Subasri, Vallijah, et al.
Publicado: (2023) -
Hematologic malignancies and Li–Fraumeni syndrome
por: Swaminathan, Mahesh, et al.
Publicado: (2019)